CCc1cccc2c(C(=O)CN3C(=O)C(=O)N(C4CCCC4)C3=O)c[nH]c12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?